Tech Company Financing Transactions
Epitel Funding Round
On 3/3/2022, Epitel raised $12.5 million in Series A funding from Catalyst Health Ventures, Genoa Ventures and Dexcom.
Transaction Overview
Company Name
Announced On
3/3/2022
Transaction Type
Venture Equity
Amount
$12,500,000
Round
Series A
Investors
Catalyst Health Ventures (Lead Investor)
Genoa Ventures (Lead Investor) (Vikram Chaudhery)
Dexcom (Andrew Rasdal)
Proceeds Purpose
The company intends to use the funds for initial pilot commercialization and further development of its proprietary platform.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
630 South Stringfellow Ct. B
Salt Lake City, UT 84111
USA
Salt Lake City, UT 84111
USA
Phone
Undisclosed
Website
Email Address
Overview
Epitel is revolutionizing how brain health is monitored by combining wearable EEG technology with cloud-based data analytics and machine-learning capabilities. We design and develop wireless solutions that provide long-term monitoring where you are, when you need it.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Lehmkuhle
Chief Operating Officer
Nico Choksi
Browse more venture capital transactions:
Prev: 3/3/2022: Atomic FI venture capital transaction
Next: 3/3/2022: Owner.com venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs